As a pharmaceutical company, a 15 times PE is not unusual. Consistent results give us a view that it should have a minimum of 15 times of it EPS. A continue call for accumulation.
An emerging diversified private investment fund
As a pharmaceutical company, a 15 times PE is not unusual. Consistent results give us a view that it should have a minimum of 15 times of it EPS. A continue call for accumulation.
Leave a Reply